{
    "code": 0,
    "data": [
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Quarter-3 ended on December 31 2025.",
            "news_id": "0977b86c-b647-485f-b3f5-aa1e8dcf9fe6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fdc72b0-91a1-4189-bbc2-24c2d64cec2a.pdf",
            "news_date": "2026-02-12 18:32:19",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Quarter III ended on December 31 2025.",
            "news_id": "b76a846b-2f32-47a8-8d18-cf26d0c4c9d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a21b328-f927-43c9-83cb-c1112f37bf04.pdf",
            "news_date": "2026-02-11 19:28:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarterly Results",
            "news_body": "Unaudited limited reviewed Standalone & Consolidated Financial Results of the Company for the quarter and year to date period ended on December 31 2025.",
            "news_id": "371e5039-a2c6-4946-93de-adcb8e737582",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7296e13a-19e7-4b8d-8f4f-d497f8f722a0.pdf",
            "news_date": "2026-02-11 17:43:57",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/ Investors Earning call held with public at large on November 11 2025 for the quarter ended September 2025",
            "news_id": "f42da8ce-5887-4af6-94c8-9d0d412c32b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4424c13c-8f23-49e1-b630-4d5464d9f240.pdf",
            "news_date": "2025-11-17 16:05:26",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Earnings call for the Financial Results of the Company for the Q-2 & Half year ended on September 30 2025.",
            "news_id": "31cbd9bf-7dee-471d-ae2d-56e35f82f027",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8416c4-c432-4e44-bf69-63627f93f764.pdf",
            "news_date": "2025-11-11 19:23:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Analysts/Investors Earnings Call for the Q-2 & Half Year for F.Y.2025-26 ended on September 30 2025.",
            "news_id": "1612b59d-96be-4b94-b5cf-eb6f28971d0c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d207b0b0-043d-4d16-b3d5-57a929c180cd.pdf",
            "news_date": "2025-11-11 15:37:21",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Limited Reviewed Financial Results For Q-2 Of F.Y.2025-26",
            "news_body": "Unaudited Limited Reviewed Financial Results for the Q-2 & Half Year ended on September 30 2025",
            "news_id": "92f7d760-954a-4353-856d-573a3098f445",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e8feff4-1fe0-4fc1-9d32-faa9109a5f68.pdf",
            "news_date": "2025-11-11 15:28:09",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst / Investors earning call held with public at large on 12th August 2025- Orchid Pharma Limited.",
            "news_id": "0687a381-23d8-400e-ba51-8e36b43fcf6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fae146e7-56e5-4373-9698-6e93c752fd5c.pdf",
            "news_date": "2025-08-14 17:07:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Intimation of Audio Recording of the Investors/Earnings call for the Q-1 of F.Y.2025-26 ended June 30 2025.",
            "news_id": "b7d64188-2d9a-4729-a09f-12fba87258d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5974295d-425e-4088-a9e9-7c76f1902162.pdf",
            "news_date": "2025-08-12 19:49:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Investor Presentation for the financial results of Q-1 of F.Y.25-26",
            "news_id": "615608d0-6b8b-4d25-9d2b-9f74977c339f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e356cbc-55b6-49b8-8e6b-a336760bb3e6.pdf",
            "news_date": "2025-08-12 16:08:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Inter-Alia For Consideration And Approval Of Financial Results For The Q-1 Of F.Y.2025-26 Ended On June 30 2025",
            "news_body": "Outcome of Board Meeting inter-alia for consideration and approval of Financial Results for the Q-1 of F.Y.2025-26 ended on June 30 2025.",
            "news_id": "3e48d2a1-815b-4282-9fe7-bca460f6c912",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab6569cb-597c-4a53-9317-d573b934fdd2.pdf",
            "news_date": "2025-08-12 15:57:06",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor Earning Call held with public at large on May 26 2025 on financial performance/ financial results for the Quarter-IV and Financial Year ended on March 31 2025.",
            "news_id": "87f89c81-1314-4ac7-9b72-75ff34715d48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcf5f67e-4d5b-4737-90a6-03c6644f124a.pdf",
            "news_date": "2025-06-02 17:21:48",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)",
            "news_id": "3663ec85-956a-4d0b-b181-1df3552d1a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48115633-c9d9-45f6-83e3-e1c4500f3cd6.pdf",
            "news_date": "2025-05-26 21:46:37",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for quarterly and Annual Financial Results for the period ended on March 31 2025",
            "news_id": "2598a0b5-ec49-4ac8-b0c6-bf4f2635a4be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4636c79d-2779-45fd-90b0-bbb702ff8caa.pdf",
            "news_date": "2025-05-26 16:14:49",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31 2025",
            "news_body": "Annual Audited Financial Results for the quarter and F.Y.2025",
            "news_id": "ca90cf4e-be3e-4fb4-aa6b-ba152e44e890",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01febc5e-06ff-4950-b96a-bc83e42d038a.pdf",
            "news_date": "2025-05-26 16:06:59",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst/ Investor earning call held with public at large on February 12 2025 for Financial Results of Quarter III of FY 2024-25 ended on December 31 2024- Orchid Pharma Limited",
            "news_id": "684d878f-4570-4446-a475-7a0426b1c6ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba7c57c-42b0-4766-9e96-76f618bc6b91.pdf",
            "news_date": "2025-02-15 16:05:32",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Analysts/Earnings Call for Quarter-III of F.Y.2024-25 ended on December 31 2024.",
            "news_id": "e8af317d-e2e9-42c2-82d7-ace81a45f4d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a747e4a9-cd5b-43b3-8f2e-40c079aaaf9f.pdf",
            "news_date": "2025-02-12 15:55:39",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held For Inter Alia Consideration And Approval Of Unaudited Limited Reviewed Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On Decemb",
            "news_body": "Outcome of the Board Meeting including inter alia Financial Results for the quarter ended on December 31 2024.",
            "news_id": "bb4554c7-e5fd-4b39-aa6a-cfc2dce876d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43359b09-b28e-47da-96e3-a304163e4fff.pdf",
            "news_date": "2025-02-12 15:42:07",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Analysts/Investors Earning Call held on November 11, 2024 on the Financial Performance of the Company for the Quarter and Half Year ended on September 30, 2024.",
            "news_id": "b4987802-972a-4ed6-b6cf-f757a859e2fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd7ca577-5c5b-4336-b529-f3dc78144921.pdf",
            "news_date": "2024-11-15 13:10:42",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call held on November 11, 2024",
            "news_id": "6a5cec52-a770-466b-a81d-be9e155d19d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb6e04e-8096-481c-9de5-b591e1bae79a.pdf",
            "news_date": "2024-11-11 18:55:28",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Earnings/Investors Calls scheduled to be held on November 11, 2024",
            "news_id": "ee7cf212-0103-4e3f-a41a-fb6073a12000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=973e25de-97c7-444b-a731-5642d7e8bfc2.pdf",
            "news_date": "2024-11-11 15:32:05",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2024",
            "news_body": "Unaudited Financial Results for the Quarter and Half Year ended on September 30, 2024",
            "news_id": "30f4d116-7926-4c0e-a78e-c478df15f1e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d86b0ab-48fa-4fbc-b14a-f3ff9f954160.pdf",
            "news_date": "2024-11-11 15:10:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/ Investors Earning Call for the Financial Results of the Company for the Quarter- 1 of Financial Year 2024-25, ended on June 30, 2024.",
            "news_id": "4782480b-acb9-4fe5-971a-6f029d24e4da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99977bd2-71eb-493d-a563-5b112ac1b2f0.pdf",
            "news_date": "2024-08-17 19:00:54",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Financial Results of Quarter-1 of Financial Year-2024-25, ended on June 30, 2024",
            "news_id": "500ad0b5-61e7-4eb5-bd17-04a7dafdb95e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fcf20b9-942d-4494-a040-32d997bd8e2c.pdf",
            "news_date": "2024-08-13 20:13:08",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Analysts/ Earnings Call for Quarter-1 of F.Y.2024-25, ended on June 30, 2024",
            "news_id": "b1ddbd37-0b4f-4062-aa23-0b08e9cc07ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ab4b5c0-26de-4869-ba25-fd58974cebed.pdf",
            "news_date": "2024-08-13 14:54:53",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Qtr June 2024",
            "news_body": "Financial Results for the quarter ended June 2024",
            "news_id": "39fb8502-b387-4254-8288-3c7b53c40a43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01292b1b-b156-42ba-9183-e2f424bd62ff.pdf",
            "news_date": "2024-08-12 19:29:20",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Investor/Analysts Earnings Call held on May 24, 2024.",
            "news_id": "edc3b9ba-51cb-470d-8502-197502ad18cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b22861ec-3c50-416e-897d-97aa40d2498d.pdf",
            "news_date": "2024-05-29 17:54:43",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analysts/Investors Earnings Call held today i.e. May 24, 2024 at 04:00 P.M. (IST) to discuss the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended on March 31, 2024.",
            "news_id": "b82a94e2-b2e5-452d-88f9-f897040184a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83cf7263-544d-40b0-bbea-655e9b257477.pdf",
            "news_date": "2024-05-24 20:49:36",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4- Financial Year 2023-24",
            "news_id": "992c0bc4-d1d3-4245-8e2c-231c03dbba59",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa33e2d1-2388-4fb0-9240-54ebf4b6ebaa.pdf",
            "news_date": "2024-05-23 21:56:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For Financial Year Ended On March 31, 2024",
            "news_body": "Audited Financial Results along with Auditor''s Report for Financial Year ended on March 31, 2024",
            "news_id": "75466cf2-7482-4f23-922a-80b45e72d1bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31a6c667-0f71-41f3-ab03-0fe76460765b.pdf",
            "news_date": "2024-05-23 20:17:04",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Earning Call Transcript",
            "news_id": "26f93800-45f9-439b-ab5d-8fa820aec07c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31053f17-cf09-4489-985d-aec06571372c.pdf",
            "news_date": "2024-02-13 17:50:14",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the Investor Presentation on the financial highlights of the Company w.r.t the quarter ended on December 31, 2023.",
            "news_id": "7918bc04-caf3-4aa4-81c6-79df1d718430",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02cc107a-d794-4d31-8259-28892be8a3f6.pdf",
            "news_date": "2024-02-08 23:28:24",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Quarter Ended On December 31, 2023",
            "news_body": "Financial Results for the Quarter ended on December 31, 2023",
            "news_id": "57bfe0af-851e-42b1-9dda-efb0a80a3e5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86596dc6-c5b4-45fc-9044-c65291cf7e87.pdf",
            "news_date": "2024-02-08 15:54:18",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Meeting and Road Show",
            "news_id": "bc64a0a9-e2e2-4e4a-85d5-0e9b6d5d42e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86ab5d16-c66f-4fcd-a862-71fa226867ef.pdf",
            "news_date": "2023-11-20 17:11:56",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under Regulation 30 (LODR) - Earning Call Transcript",
            "news_id": "87a51fd2-b6ab-458f-9176-24fce9d34ba8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57960835-3b34-44c1-bffc-ff6eb71f405f.pdf",
            "news_date": "2023-11-10 12:59:21",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Announcement under Regulation 30 (LODR)-Investor Call Audio Recording",
            "news_id": "b6da737d-1118-4c46-b546-5acfa436058a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a0ecca0-1137-4e4e-b291-17c158d206d2.pdf",
            "news_date": "2023-11-06 21:04:13",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Investor Presentation",
            "news_id": "07683689-7b72-422c-8003-c5b546a8ab0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cb5f432-19fc-476b-a7d3-1a385bf9b15c.pdf",
            "news_date": "2023-11-06 15:13:44",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited (Standalone & Consolidated) Financial Results For The Period  Ended September 30, 2023",
            "news_body": "Approval of Unaudited (Standalone & Consolidated) Financial Results for the period ended September 30, 2023",
            "news_id": "59916408-2eb4-4d2c-800b-d9721bfe342e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7217162-0c27-4d41-b2b3-06632199ff92.pdf",
            "news_date": "2023-11-04 18:58:12",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Transcript of Earning Call for quarter ended June 30, 2023.",
            "news_id": "fa96c488-a43b-4664-ad42-69d872242dc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19cf69fa-8f5d-4883-ac5a-45efa85e6df4.pdf",
            "news_date": "2023-08-21 15:29:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Investor Call",
            "news_id": "d0b20b1b-2662-4f73-8821-0e869d51c765",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b3ca8ea-39fb-423a-b1b6-9c6efb8d3e1c.pdf",
            "news_date": "2023-08-14 18:44:41",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "07f7eec1-450b-43ee-8f72-116ae55813ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae43f24-f270-4faf-8a3b-e9dfd8a5d1ea.pdf",
            "news_date": "2023-08-14 15:23:52",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Transcript of the Investor call",
            "news_id": "be4cf52a-9ee9-4157-8ca2-b082fa413c27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309f1f21-faef-4672-8785-d4255f678a54.pdf",
            "news_date": "2023-05-18 17:26:28",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Outcome/Audio Recording of the Investor Call",
            "news_id": "337a319d-689a-44ec-9395-95e5630ecbdd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb69f3a1-680e-4bc3-a88f-25d34418803e.pdf",
            "news_date": "2023-05-11 17:50:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome - Audited Financial Results For Period Ended March 31, 2023",
            "news_body": "Board Meeting outcome - Audited Financial Results for period ended March 31, 2023",
            "news_id": "2fb6664b-0ccd-4503-a18e-aecb7228add2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15a10a89-e9d2-4927-bb25-e13a4fdbd5e6.pdf",
            "news_date": "2023-05-10 22:11:57",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Investor call/earning call held on February 17, 2023.",
            "news_id": "82b8ef86-0f54-40df-ac46-6f82e8471c42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df98fc38-6909-4c21-a8da-6fc6a553bab1.pdf",
            "news_date": "2023-02-22 16:16:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approved Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended December 31, 2022.",
            "news_body": "Approved Un-Audited Financial Results (Standalone & Consolidated) for quarter ended December 31, 2022.",
            "news_id": "97f5fb02-651d-4c30-9ff8-c52911c8f330",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13afc985-843c-4905-aec9-5ad9c23b6fd3.pdf",
            "news_date": "2023-02-09 18:34:04",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Analyst/Investor Meetings of the Company",
            "news_id": "80658f29-9fa1-478a-8b4a-ef958a0b926f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1ac8f1e-43b9-4224-9823-264f64336d7e.pdf",
            "news_date": "2022-12-15 15:00:55",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "6634aa16-f0bc-401d-bb25-e3fab3518632",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=609fa197-e1c0-4111-9d9f-3f738180ec6e.pdf",
            "news_date": "2022-11-28 18:57:29",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Orchid Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call",
            "news_id": "9cab6b19-cadf-4f22-96bf-227d327cfab3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=244a778e-64dd-40d5-8e88-5e6ee60486f5.pdf",
            "news_date": "2022-11-23 17:39:02",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Investor Call held on November 18, 2022.",
            "news_id": "7dc7a87b-4e89-4164-af9b-2779f072720a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=858e5d80-277d-476a-9d73-847f84372040.pdf",
            "news_date": "2022-11-18 18:24:05",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Un-Audited Financial Results Of The Company For Quarter And Half Year Ended Sept. 30, 2022.",
            "news_body": "Approval of the Un-Audited Financial results of the Company for quarter and half year ended Sept. 30, 2022.",
            "news_id": "712b6f01-3c14-4acc-be37-1e830eadf73f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85fb462c-e691-4852-bc78-b5e9b2a719af.pdf",
            "news_date": "2022-11-14 17:33:03",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analysts/Investors Conference Call pertaining to the Financial Results for the Quarter ended June 30, 2022",
            "news_id": "d11acf01-fee3-4f3e-8a75-26066d11d43c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0713971-a80a-42c3-9e6d-8d7a305f91f2.pdf",
            "news_date": "2022-08-17 18:19:22",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended June 30Th 2022",
            "news_body": "Un-Audited Financial Results for the Quarter ended June 30th 2022",
            "news_id": "50da52b8-b9fe-4a9e-bfc8-c921215f58b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae1c111b-8930-42f8-a734-d49122ccf144.pdf",
            "news_date": "2022-08-10 16:29:11",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation on Un-Audited Standalone & Consolidated Financial Results for the Quarter Ended 30 June, 2022",
            "news_id": "69297f68-2aad-4885-833f-09e34ab85570",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=020b984a-c33d-448e-984f-635e06e3ac80.pdf",
            "news_date": "2022-08-10 15:57:30",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "57c0b894-acc8-4b26-8355-c6052abf15db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a53ca327-0c79-4ede-9d81-cc3d79c80d34.pdf",
            "news_date": "2022-06-20 11:16:14",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Revised Outcome",
            "news_body": "Revised outcome - Audited financial results-March 31,2022-Legible format",
            "news_id": "9f77c31f-043d-49b0-9ed9-5078a4adec3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d29ba818-5306-47f1-804a-06329d003d94.pdf",
            "news_date": "2022-05-17 19:35:01",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Financial Year Ended March 31,2022",
            "news_body": "Audited financial results for the financial year ended March 31,2022",
            "news_id": "0bc8e20c-e81f-417c-8d5e-67079730701d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c832321-8e74-4ee7-a305-9a99f093873b.pdf",
            "news_date": "2022-05-12 21:48:41",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting-May 12,2022",
            "news_body": "Outcome of Board meeting-May 12,2022-Approval of Audited financial results-March 31,2022",
            "news_id": "7515524c-bba9-4ed4-ba04-2d651ee8acc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b6246b-2e4e-4536-b8f5-f92e938ee4c3.pdf",
            "news_date": "2022-05-12 21:44:51",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings conference call (Q3FY2022) held on February 18, 2022",
            "news_id": "71f899c0-43c7-46f4-b187-54c86fc66074",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72a45a4-6bd0-4c6d-ae41-983544d173c9.pdf",
            "news_date": "2022-02-24 20:21:52",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31,2021",
            "news_body": "Unaudited financial results for the quarter and nine months ended December 31,2021",
            "news_id": "f6979752-e074-401f-b388-9678172c995c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670f4d71-eb1c-4fe8-a0ac-27a21919b832.pdf",
            "news_date": "2022-02-12 18:34:06",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 12,2022",
            "news_body": "Outcome of Board meeting held on February 12,2022",
            "news_id": "dab0d5cf-e12c-4050-9313-590225403dc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d69800a5-e90d-4d0f-8524-29f413dd5c4b.pdf",
            "news_date": "2022-02-12 18:28:44",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI(LODR) Regulations,2015- Investor presentation",
            "news_id": "4c39aaf8-70b7-48fa-9902-8e8b1c05f89d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf299d34-225b-4f36-8e3c-9cc490f0e8b0.pdf",
            "news_date": "2021-12-23 14:22:40",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on proposed Related Party Transactions",
            "news_id": "e5d654db-7502-46ee-95d5-5ae4f75ae8f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2b4e36f-9685-450b-b9a0-8012f306da98.pdf",
            "news_date": "2021-11-23 18:33:43",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30,2021",
            "news_body": "Unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30,2021",
            "news_id": "66d596e7-83f7-48be-a7b3-68e7cf461fb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a119570-b2f8-4354-b003-58694adda02d.pdf",
            "news_date": "2021-11-14 22:12:26",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited Financial Results (Standalone And<BR> Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and<BR> Consolidated) for the Quarter and Half Year ended September 30, 2021",
            "news_id": "b51998ae-b2dc-4a5e-95f9-08a7afcfa320",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2233f8f-b953-4c90-a9cb-fcfbf2e69483.pdf",
            "news_date": "2021-11-14 22:05:03",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2021",
            "news_id": "8807cb79-5bcd-45ca-b42f-678387401847",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6089ce3d-68ab-4e09-8e66-d1e11f721c31.pdf",
            "news_date": "2021-08-13 20:36:15",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited Financial Results (Standalone And Consolidated)<BR> For The Quarter Ended June 30, 2021",
            "news_body": "Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and Consolidated)<BR> for the Quarter ended June 30, 2021",
            "news_id": "4517aa67-daf2-4a50-8eb2-f0787d08ca5e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e236aac-02d4-4e40-a7af-e9ab4f88eab7.pdf",
            "news_date": "2021-08-13 20:20:58",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor presentation",
            "news_id": "4cb0ac1c-a3c7-4e67-b48d-9955dacd0a98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd6f103a-349e-4563-9ac4-8d9170097677.pdf",
            "news_date": "2021-06-16 11:06:15",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015- Investor Presentation",
            "news_id": "1867e587-4c93-4b94-a082-b21563857102",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=292049f5-2c55-4478-96d4-3809ec567e1c.pdf",
            "news_date": "2021-06-09 13:50:47",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor Presentation",
            "news_id": "71b15374-c7fa-43d2-869d-00c9d3f4ad80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc25031a-9813-4060-84c9-12b205b97f2c.pdf",
            "news_date": "2021-06-09 10:51:00",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ORCHPHARMA",
            "disp": "Orchid Pharma",
            "bse_code": 524372,
            "isin": "INE191A01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated ) For The Fourth Quarter And Financial Year Ended March 31,2021",
            "news_body": "Audited financial results (Standalone and Consolidated ) for the fourth quarter and financial year ended March 31,2021",
            "news_id": "0eac7c65-866c-40d9-b786-9a69961a6fc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c32806c4-a3d8-4582-bee1-5f53ad92188b.pdf",
            "news_date": "2021-05-22 20:32:16",
            "seo": "orchid-chemicals-pharmaceuticals-ltd",
            "ltp": 689.8,
            "ch": 1.25,
            "pch": 0.18154091932321548,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 926,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}